93 results
Page 4 of 5
8-K
EX-99.1
snm8fhx
11 Feb 19
Company now focused on completing plan to resubmit NDA in first half of 2019
5:00pm
424B5
cy32i8l 9f
23 Jan 19
Prospectus supplement for primary offering
8:01am
8-K
EX-99.2
j9agn7le k7zs6y
24 Oct 18
Other Events
8:13am
8-K
EX-99.1
ge9nb35g
3 Aug 18
Agile Therapeutics Reports Second Quarter 2018 Financial Results
8:12am
8-K
EX-99.1
2vygbr
24 Jul 18
Company Plans to Appeal to the FDA’s Office of New Drugs
4:20pm
8-K
EX-99.1
nrt9m
4 May 18
Other Events
8:30am
8-K
EX-99.1
pptkeil9o rpogrpcqb9
27 Apr 18
Other Events
4:31pm